1. Rare Genetic Diseases with Defects in DNA Repair: Opportunities and Challenges in Orphan Drug Development for Targeted Cancer Therapy
   Sonali Bhattacharjee et al, 2018, Cancers CrossRef
2. Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells
   Andrea Ghelli Luserna Di Rorà et al, 2023, Cell Biology and Toxicology CrossRef
3. Polyploidy and Mitotic Cell Death Are Two Distinct HIV-1 Vpr-Driven Outcomes in Renal Tubule Epithelial Cells
   Emily H. Payne et al, 2018, Journal of Virology CrossRef
4. XRCC1 deficient triple negative breast cancers are sensitive to ATR, ATM and Wee1 inhibitor either alone or in combination with olaparib
   Reem Ali et al, 2020, Therapeutic Advances in Medical Oncology CrossRef
5. Chemical inhibition of DNA repair kinases as a promising tool in oncology
   Kamila Durisova et al, 2016, Biomedical Papers CrossRef
6. Reduction of SCUBE3 by a new marine-derived asterosaponin leads to arrest of glioma cells in G1/S
   Peng-Cheng Qiu et al, 2020, Oncogenesis CrossRef
7. Stress-sensing in the human greying hair follicle: Ataxia Telangiectasia Mutated (ATM) depletion in hair bulb melanocytes in canities-prone scalp
   Stephen K. Sikkink et al, 2020, Scientific Reports CrossRef
8. Ataxia‐Telangiectasia Mutated Kinase: A Potential New Target for Suppressing Inflammation in Heart Failure?
   Rakesh C. Kukreja, 2014, Journal of the American Heart Association CrossRef
9. Clinically Applicable Inhibitors Impacting Genome Stability
   Anu Prakash et al, 2018, Molecules CrossRef
10. DNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles’ Heel of Cancer
    Denis Velic et al, 2015, Biomolecules CrossRef
11. Uncovering Cell Cycle Dysregulations and Associated Mechanisms in Cancer and Neurodegenerative Disorders: A Glimpse of Hope for Repurposed Drugs
    Dia Advani et al, 2024, Molecular Neurobiology CrossRef
12. The novel ATM inhibitor (AZ31) enhances antitumor activity in patient derived xenografts that are resistant to irinotecan monotherapy
    Justin Greene et al, 2017, Oncotarget CrossRef
13. How Different Are the Molecular Mechanisms of Nodal and Distant Metastasis in Luminal A Breast Cancer?
    Petr Lapcik et al, 2020, Cancers CrossRef